The acidic amino acids are Aspartate and Glutamate, both of which have carboxylate groups in their side chains.

Titration of a weak acid with a strong base

• A weak acid is mostly in its conjugate acid form

• When strong base is added, it removes protons from the solution, more and more acid is in the conjugate base form, and the pH increases

• When the moles of base added equals half the total moles of acid, the weak acid and its conjugate base are in equal amounts. The ratio of CB / WA = 1 and according to the HH equation, pH = pKa + log(1) or pH = pKa.

• If more base is added, the conjugate base form becomes greater till the equivalance point when all of the acid is in the conjugate base form.

Protein folding is essential for proper biological function. When folding goes wrong, it can trigger a cascade of pathological effects. Here are three key examples:

1. Alzheimer’s Disease

• Misfolded Protein: Amyloid-β (Aβ) and tau

• Mechanism:

  • Aβ peptides misfold and aggregate into amyloid plaques in the brain.

  • Tau proteins form neurofibrillary tangles inside neurons.

• Impact:

  • Neuronal death, memory loss, cognitive decline.

  • Progressive neurodegeneration.

• Fun Fact: These plaques can be seen in brain imaging and are a hallmark of Alzheimer’s pathology.

 2. Prion Diseases (e.g., Mad Cow Disease, Creutzfeldt-Jakob Disease)

• Misfolded Protein: Prion protein (PrP^Sc)

• Mechanism:

  • Normal prion protein (PrP^C) misfolds into a pathogenic form (PrP^Sc).

  • PrP^Sc induces other prion proteins to misfold, creating a chain reaction.

• Impact:

  • Rapid brain degeneration, motor dysfunction, fatal outcomes.

  • No immune response—prions are host proteins, not foreign invaders.

• Unique Feature: Prions are infectious proteins—no DNA or RNA involved.

 3. Sickle Cell Anemia

• Misfolded Protein: Hemoglobin (HbS mutation)

• Mechanism:

  • A single amino acid substitution (valine for glutamic acid) in β-globin.

  • Causes hemoglobin to polymerize under low oxygen, distorting red blood cells into a sickle shape.

• Impact:

  • Blocked blood flow, pain crises, organ damage.

  • Reduced oxygen-carrying capacity.

• Note: Unlike amyloid diseases, this is a structural misfolding due to a genetic mutation.

TRIGLYCEROL

Triacylglycerols (formerly triglycerides) are the esters of glycerol with fatty acids. The fats and oils that are widely distributed in both  plants and animals are chemically triacylglycerols.

They are insoluble in water and non-polar in character and commonly known as neutral fats.

Triacylglycerols are the most abundant dietary lipids. They are the form in which we store reduced carbon for energy. Each triacylglycerol has a glycerol backbone to which are esterified 3 fatty acids. Most triacylglycerols are "mixed." The three fatty acids differ in chain length and number of double bonds

Structures of acylglycerols :

Monoacylglycerols,  diacylglycerols and triacylglycerols, respectively consisting of one, two and three molecules of fatty acids esterified to

a molecule of glycerol

Lipases hydrolyze triacylglycerols, releasing one fatty acid at a time, producing  diacylglycerols, and eventually glycerol

Glycerol arising from hydrolysis of triacylglycerols is converted to the Glycolysis intermediate dihydroxyacetone phosphate, by reactions catalyzed by:
(1) Glycerol Kinase
(2) Glycerol Phosphate Dehydrogenase

Free fatty acids, which in solution have detergent properties, are transported in the blood bound to albumin, a serum protein produced by the liver.
Several proteins have been identified that facilitate transport of long chain fatty acids into cells, including the plasma membrane protein CD36

Acyl-CoA Synthases (Thiokinases), associated with endoplasmic reticulum membranes and the outer mitochondrial membrane, catalyze activation of long chain fatty acids, esterifying them to coenzyme A, as shown at right. This process is ATP-dependent, and occurs in 2 steps. There are different Acyl-CoA Synthases for fatty acids of different chain lengths. 

Exergonic hydrolysis of PP_i (P~P), catalyzed by Pyrophosphatase, makes the coupled reaction spontaneous. Overall, two ~P bonds of ATP are cleaved during fatty acid activation. The acyl-coenzyme A product includes one "high energy" thioester linkage.

Summary of fatty acid activation:

• fatty acid + ATP → acyl-adenylate + PP_i
  PP_i  → P_i
• acyladenylate + HS-CoA → acyl-CoA + AMP

Overall: fatty acid + ATP + HS-CoA → acyl-CoA + AMP +  2 P_i

For most steps of the b-Oxidation Pathway, there are multiple enzymes specific for particular fatty acid chain lengths.

Fatty acid b-oxidation is considered to occur in the mitochondrial matrix. Fatty acids must enter the matrix to be oxidized. However enzymes of the pathway specific for very long chain fatty acids are associated with the inner mitochondrial membrane (facing the matrix).

Fatty acyl-CoA formed outside the mitochondria can pass through the outer mitochondrial membrane, which contains large VDAC channels, but cannot penetrate the mitochondrial inner membrane.

Transfer of the fatty acid moiety across the inner mitochondrial membrane involves carnitine.

Carnitine Palmitoyl Transferases catalyze transfer of a fatty acid between the thiol of Coenzyme A and the hydroxyl on carnitine.

Carnitine-mediated transfer of the fatty acyl moiety into the mitochondrial matrix is a 3-step process, as presented below.

1. Carnitine Palmitoyl Transferase I, an enzyme associated with the cytosolic surface of the outer mitochondrial membrane, catalyzes transfer of a fatty acid from ester linkage with the thiol of coenzyme A to the hydroxyl on carnitine.
2. Carnitine Acyltransferase, an antiporter in the inner mitochondrial membrane, mediates transmembrane exchange of fatty acyl-carnitine for carnitine.
3. Within the mitochondrial matrix (or associated with the matrix surface of the inner mitochondrial membrane, Carnitine Palmitoyl Transferase II catalyzes transfer of the fatty acid from carnitine to coenzyme A. (Carnitine exits the matrix in step 2.) The fatty acid is now esterified to coenzyme A within the mitochondrial matrix

Control of fatty acid oxidation is exerted mainly at the step of fatty acid entry into mitochondria.

Malonyl-CoA inhibits Carnitine Palmitoyl Transferase I. (Malonyl-CoA is also a precursor for fatty acid synthesis). Malonyl-CoA is produced from acetyl-CoA by the enzyme Acetyl-CoA Carboxylase

AMP-Activated Kinase, a sensor of cellular energy levels, catalyzes phosphorylation of Acetyl-CoA Carboxylase under conditions of high AMP (when ATP is low). Phosphorylation inhibits Acetyl-CoA Carboxylase, thereby decreasing malonyl-CoA production.

The decrease in malonyl-CoA concentration releases Carnitine Palmitoyl Transferase I from inhibition. The resulting increase in fatty acid oxidation generates acetyl-CoA for entry into Krebs cycle, with associated production of ATP

HORMONES

A hormone is a chemical that acts as a messenger transmitting a signal from one cell to another. When it binds to another cell which is the target of the message, the hormone can alter several aspects of cell function, including cell growth, metabolism, or other function.

Hormones can be classified on three primary ways as following:

1.  Autocrine: An autocrine hormone is one that acts on the same cell that released it.

2.  Paracrine: A paracrine hormone is one that acts on cells which are nearby relative to the cell which released it. An example of paracrine hormones includes growth factors, which are proteins that stimulate cellular proliferation and differentiation.

3. Endocrine: An endocrine hormone is one that is released into the bloodstream by endocrine glands. The receptor cells are distant from the source. An example of an endocrine hormone is insulin, which is released by the pancreas into the bloodstream where it regulates glucose uptake by liver and muscle cells.